drugset / Trial / NCT04467125
Nexplanon Removal: Subcutaneous vs. Topical Lidocaine
RandomizedSingle-groupOpen-labelOther
Summary
A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure and time to removal.
Timeline
- Start
- 2020-01-06
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 1 % | Subcutaneous |
| Subject | Lidocaine-Prilocaine | Unknown | — | Topical |
Indications
No indication recorded.